BioSpace News Archive

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the market closes on Friday, February 28, 2020.

Apixio Inc., the AI healthcare analytics company, today announced that it was among three companies selected by the National Committee for Quality Assurance (NCQA) to participate in the organization’s Natural Language Processing (NLP) Working Group.

Health Gorilla, a leader in clinical data APIs, and MDPortals, a leading clinical insights company, announced today a partnership to bring proprietary care insights to providers from a vast network of clinical systems.

Jackson Healthcare®, a family of highly specialized healthcare staffing, search and technology companies, announced the appointment of Scott L’Heureux to president of its nurse and allied health group.

Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice industry, announces the appointment of Scott Quilty as Chief Commercial Officer to drive Enclara’s strategic direction around business development, client services and marketing.

Those suffering from advanced neck and arm pain may find themselves to be candidates for a new clinical trial that has opened up just this week at the Los Angeles-based practice, Lanman Spinal Neurosurgery, founded by one of the world’s most prominent spinal surgeons, Dr. Todd H. Lanman.

Feb. 26, 2020 17:00 UTC Industry’s first “any drug, any time, any prescriber” approach to pharmacogenomics improves safety, lowers costs SAN DIEGO--( BUSINESS WIRE )-- MedImpact , announced today the launch of a first-of-its-kind pharmacogenomics solution that systematically reviews every prescribed drug for a patient against a patient’s genetic profile. This highly personalized approach protects patients against hundreds of ineffective and harmful drugs based on their gen

In a release issued under the same headline issued earlier by Harvard Bioscience, Inc., please note that the table titled “Consolidated Statements of Operations” had incorrect data in the first data column.

Feb. 26, 2020 13:03 UTC Veeva expands legal action to cover additional Veeva software applications as IQVIA attempts to extend monopoly control Favorable ruling would finally give life sciences companies the freedom to use the software and data products of their choice PLEASANTON, Calif.--( BUSINESS WIRE )-- Veeva Systems (NYSE: VEEV) today announced it is gaining widespread customer support for its antitrust lawsuit against IQVIA (NYSE: IQV). Six of the largest gl

Westport, CT, Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company will be presenting at the Cowen & Co. 40th Annual Health Care Conference. The Conference is being held on March 2-4, 2020 at the Boston Marriott Copl